These medications initially may cause nausea, vomiting, or diarrhea, especially early on
Semaglutide under the brand names Ozempic and Wegovy, tirzepatide under the names Mounjaro and Zepbound, and other medications in this class have demonstrated meaningful results for weight management and blood sugar control that go beyond what most previous treatment options could offer
CONSULT YOUR DOCTOR : User agrees to consult Users own medical doctor, primary care physician, or medical expert prior to purchasing any product or service from the Company through its Website
Mechanism of action of exenatide to reduce postprandial hyperglycemia in type 2 diabetes
Combined with the GLP-1-mediated improvements in insulin sensitivity and the GIP-mediated changes in lipid metabolism, the triple agonist creates conditions under which the liver clears accumulated fat at rates never before observed in clinical settings
[26] [27] Never share your GLP-1 pen with others, even if the needle is changed, due to infection risk
